InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Tuesday, 08/20/2013 8:39:56 AM

Tuesday, August 20, 2013 8:39:56 AM

Post# of 130503
The clues are all there folks; just connect the dots:

1) Friendly investor who appears to be committed to see Management execute to achieve future milestones = "Dominion"
and just may be the main Financing arm going forward = big capital raise looming here.
2) Multiple MANF Orphan IND's on the way = the technology platform is going to be HUGE (Parkinsons, Ischemic Heart disease, Opthamalogy, TBI, Diabetes....what next)?
3) Becton Dickinson alliance for LymPro (Alzheimers) - $500mm revenue potential = to be commercialized in 2014.
4) Nuropro Diagnostic blood test; can be used for the following future indications:

a)Parkinson’s disease
b)Alzheimer’s disease
c)Lou Gehrig’s disease (ALS)
d)Neuromuscular disease
e)Breast Cancer
f)Chonic Myelogenous Leukemia

5)Outstanding advisor team including people from Amgen, Novartis, Bayer, Bristol Myers Squibb.

I believe the worst is over for this company; as positive news continues to flow; the market cap. will adjust upward to reflect the progress and true underlying value of the asset base.

GLTA!!!